MedPath

Effect of Short-term Oxygen During CPET in GUCH

Not Applicable
Completed
Conditions
Grown-up Congenital Heart Disease (GUCH)
Registration Number
NCT04076501
Lead Sponsor
University of Zurich
Brief Summary

In a randomized, sham-controlled crossover trial the investigators will test whether supplemental oxygen given during cardiopulmonary exercise testing will improve exercise performance and physiological parameters in patients with grown-up congenital heart disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
7
Inclusion Criteria
  • GUCH, stable medication for at least 4 weeks.
Exclusion Criteria
  • instable status, pregnancy, clinically relevant concomitant diseases, inability to follow the study procedures

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Endurance Time (s) Endurance Time (s) Endurance Time (s)1 day

Endurance (s) with 75% Wmax measured during cardiopulmonary exercise test oxygen vs. room air

Work Rate (Watt)1 day

Maximal Work Rate (Wmax) measured during cardiopulmonary exercise test oxygen vs. room air

Secondary Outcome Measures
NameTimeMethod
Peak Oxygen uptake1 day

measured during cardiopulmonary exercise test oxygen vs. room air

Respiratory Exchange ratio1 day

measured during cardiopulmonary exercise test oxygen vs. room air

Changes in arterial blood parameters1 day

measured during cardiopulmonary exercise test oxygen vs. room air

muscle tissue oxygen1 day

Oxygen saturation in the muscle measured during cardiopulmonary exercise test oxygen vs. room air with near infrared spectroscopy

cerebral tissue oxygen1 day

Oxygen saturation in the brain measured during cardiopulmonary exercise test oxygen vs. room air with near infrared spectroscopy

Trial Locations

Locations (1)

University Hospital Zurich, Division of Pneumology

🇨🇭

Zürich, Switzerland

University Hospital Zurich, Division of Pneumology
🇨🇭Zürich, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.